nodes	percent_of_prediction	percent_of_DWPC	metapath
Nisoldipine—CYP3A4—bone cancer	0.764	1	CbGaD
Nisoldipine—CACNA1S—pes—bone cancer	0.00307	0.781	CbGeAlD
Nisoldipine—CYP1A2—Lidocaine metabolism—CYP3A4—bone cancer	0.00209	0.0596	CbGpPWpGaD
Nisoldipine—CYP3A7—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00158	0.0449	CbGpPWpGaD
Nisoldipine—Lercanidipine—CYP3A4—bone cancer	0.00117	0.14	CrCbGaD
Nisoldipine—CYP3A5—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00114	0.0325	CbGpPWpGaD
Nisoldipine—Isradipine—CYP3A4—bone cancer	0.00106	0.127	CrCbGaD
Nisoldipine—Clevidipine—CYP3A4—bone cancer	0.000933	0.112	CrCbGaD
Nisoldipine—Nimodipine—CYP3A4—bone cancer	0.000864	0.103	CrCbGaD
Nisoldipine—ABCB1—Codeine and Morphine Metabolism—CYP3A4—bone cancer	0.000863	0.0246	CbGpPWpGaD
Nisoldipine—Nilvadipine—CYP3A4—bone cancer	0.000836	0.1	CrCbGaD
Nisoldipine—Nitrendipine—CYP3A4—bone cancer	0.000836	0.1	CrCbGaD
Nisoldipine—ABCB1—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.000808	0.0231	CbGpPWpGaD
Nisoldipine—ABCB1—HIF-1-alpha transcription factor network—CITED2—bone cancer	0.000807	0.023	CbGpPWpGaD
Nisoldipine—CYP1A2—Aflatoxin B1 metabolism—CYP3A4—bone cancer	0.000767	0.0219	CbGpPWpGaD
Nisoldipine—CYP3A7—Xenobiotics—CYP3A4—bone cancer	0.00076	0.0217	CbGpPWpGaD
Nisoldipine—CYP3A5—Irinotecan Pathway—CYP3A4—bone cancer	0.000731	0.0209	CbGpPWpGaD
Nisoldipine—Amlodipine—CYP3A4—bone cancer	0.00072	0.0861	CrCbGaD
Nisoldipine—Blood urea increased—Doxorubicin—bone cancer	0.000694	0.00367	CcSEcCtD
Nisoldipine—Vaginal infection—Doxorubicin—bone cancer	0.000694	0.00367	CcSEcCtD
Nisoldipine—Abnormal vision—Epirubicin—bone cancer	0.000692	0.00367	CcSEcCtD
Nisoldipine—CACNA1S—Calcium Regulation in the Cardiac Cell—RGS1—bone cancer	0.000689	0.0197	CbGpPWpGaD
Nisoldipine—Mental disability—Epirubicin—bone cancer	0.000689	0.00365	CcSEcCtD
Nisoldipine—Alopecia—Cisplatin—bone cancer	0.000686	0.00363	CcSEcCtD
Nisoldipine—CYP1A2—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000686	0.0196	CbGpPWpGaD
Nisoldipine—CYP3A7—Metapathway biotransformation—CYP4V2—bone cancer	0.000678	0.0193	CbGpPWpGaD
Nisoldipine—Cramps of lower extremities—Doxorubicin—bone cancer	0.000675	0.00357	CcSEcCtD
Nisoldipine—Rash maculo-papular—Doxorubicin—bone cancer	0.000668	0.00353	CcSEcCtD
Nisoldipine—Flatulence—Cisplatin—bone cancer	0.000666	0.00353	CcSEcCtD
Nisoldipine—Felodipine—CYP3A4—bone cancer	0.000666	0.0796	CrCbGaD
Nisoldipine—Mouth ulceration—Doxorubicin—bone cancer	0.000664	0.00352	CcSEcCtD
Nisoldipine—Ecchymosis—Doxorubicin—bone cancer	0.000664	0.00352	CcSEcCtD
Nisoldipine—Diabetes mellitus—Epirubicin—bone cancer	0.000663	0.00351	CcSEcCtD
Nisoldipine—Dermatitis exfoliative—Methotrexate—bone cancer	0.000653	0.00346	CcSEcCtD
Nisoldipine—Muscle spasms—Cisplatin—bone cancer	0.00065	0.00344	CcSEcCtD
Nisoldipine—Hypertonia—Doxorubicin—bone cancer	0.000644	0.00341	CcSEcCtD
Nisoldipine—Nifedipine—CYP3A4—bone cancer	0.000644	0.077	CrCbGaD
Nisoldipine—Abnormal vision—Doxorubicin—bone cancer	0.000641	0.00339	CcSEcCtD
Nisoldipine—Mental disability—Doxorubicin—bone cancer	0.000637	0.00337	CcSEcCtD
Nisoldipine—Cardiac failure congestive—Epirubicin—bone cancer	0.000635	0.00336	CcSEcCtD
Nisoldipine—Nicardipine—CYP3A4—bone cancer	0.000634	0.0758	CrCbGaD
Nisoldipine—Tremor—Cisplatin—bone cancer	0.000633	0.00335	CcSEcCtD
Nisoldipine—Cerebrovascular accident—Methotrexate—bone cancer	0.000628	0.00333	CcSEcCtD
Nisoldipine—Ill-defined disorder—Cisplatin—bone cancer	0.000627	0.00332	CcSEcCtD
Nisoldipine—Anaemia—Cisplatin—bone cancer	0.000625	0.00331	CcSEcCtD
Nisoldipine—Increased appetite—Epirubicin—bone cancer	0.000613	0.00325	CcSEcCtD
Nisoldipine—Diabetes mellitus—Doxorubicin—bone cancer	0.000613	0.00325	CcSEcCtD
Nisoldipine—Dermatitis exfoliative—Epirubicin—bone cancer	0.000611	0.00323	CcSEcCtD
Nisoldipine—Malaise—Cisplatin—bone cancer	0.000609	0.00323	CcSEcCtD
Nisoldipine—Leukopenia—Cisplatin—bone cancer	0.000605	0.0032	CcSEcCtD
Nisoldipine—Cerebrovascular accident—Epirubicin—bone cancer	0.000588	0.00311	CcSEcCtD
Nisoldipine—Cardiac failure congestive—Doxorubicin—bone cancer	0.000588	0.00311	CcSEcCtD
Nisoldipine—Ataxia—Methotrexate—bone cancer	0.000579	0.00307	CcSEcCtD
Nisoldipine—Gastrointestinal haemorrhage—Epirubicin—bone cancer	0.000576	0.00305	CcSEcCtD
Nisoldipine—Myalgia—Cisplatin—bone cancer	0.000575	0.00305	CcSEcCtD
Nisoldipine—Anxiety—Cisplatin—bone cancer	0.000573	0.00304	CcSEcCtD
Nisoldipine—CYP3A5—Aflatoxin activation and detoxification—CYP3A4—bone cancer	0.000572	0.0163	CbGpPWpGaD
Nisoldipine—Liver function test abnormal—Methotrexate—bone cancer	0.000569	0.00301	CcSEcCtD
Nisoldipine—Discomfort—Cisplatin—bone cancer	0.000568	0.00301	CcSEcCtD
Nisoldipine—Increased appetite—Doxorubicin—bone cancer	0.000568	0.003	CcSEcCtD
Nisoldipine—Migraine—Epirubicin—bone cancer	0.000567	0.003	CcSEcCtD
Nisoldipine—Dermatitis exfoliative—Doxorubicin—bone cancer	0.000565	0.00299	CcSEcCtD
Nisoldipine—CACNB2—Regulation of insulin secretion—GNA11—bone cancer	0.00056	0.016	CbGpPWpGaD
Nisoldipine—CACNA1D—Calcium Regulation in the Cardiac Cell—RGS1—bone cancer	0.000559	0.016	CbGpPWpGaD
Nisoldipine—Face oedema—Epirubicin—bone cancer	0.000556	0.00295	CcSEcCtD
Nisoldipine—Oedema—Cisplatin—bone cancer	0.000552	0.00292	CcSEcCtD
Nisoldipine—CYP3A5—Xenobiotics—CYP3A4—bone cancer	0.000549	0.0157	CbGpPWpGaD
Nisoldipine—Cerebrovascular accident—Doxorubicin—bone cancer	0.000544	0.00288	CcSEcCtD
Nisoldipine—Ataxia—Epirubicin—bone cancer	0.000542	0.00287	CcSEcCtD
Nisoldipine—Tachycardia—Cisplatin—bone cancer	0.000538	0.00285	CcSEcCtD
Nisoldipine—Gastrointestinal haemorrhage—Doxorubicin—bone cancer	0.000533	0.00282	CcSEcCtD
Nisoldipine—Hyperhidrosis—Cisplatin—bone cancer	0.000533	0.00282	CcSEcCtD
Nisoldipine—Asthma—Methotrexate—bone cancer	0.000532	0.00282	CcSEcCtD
Nisoldipine—Liver function test abnormal—Epirubicin—bone cancer	0.000532	0.00282	CcSEcCtD
Nisoldipine—CACNA1D—Regulation of insulin secretion—GNA11—bone cancer	0.00053	0.0151	CbGpPWpGaD
Nisoldipine—CYP3A4—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000529	0.0151	CbGpPWpGaD
Nisoldipine—CYP3A5—Tamoxifen metabolism—CYP3A4—bone cancer	0.000528	0.0151	CbGpPWpGaD
Nisoldipine—Dry skin—Epirubicin—bone cancer	0.000528	0.0028	CcSEcCtD
Nisoldipine—Orthostatic hypotension—Epirubicin—bone cancer	0.000526	0.00279	CcSEcCtD
Nisoldipine—Anorexia—Cisplatin—bone cancer	0.000526	0.00278	CcSEcCtD
Nisoldipine—Migraine—Doxorubicin—bone cancer	0.000525	0.00278	CcSEcCtD
Nisoldipine—Hypokalaemia—Epirubicin—bone cancer	0.000524	0.00278	CcSEcCtD
Nisoldipine—Hypotension—Cisplatin—bone cancer	0.000515	0.00273	CcSEcCtD
Nisoldipine—Face oedema—Doxorubicin—bone cancer	0.000515	0.00273	CcSEcCtD
Nisoldipine—Gastritis—Epirubicin—bone cancer	0.00051	0.0027	CcSEcCtD
Nisoldipine—Muscular weakness—Epirubicin—bone cancer	0.000508	0.00269	CcSEcCtD
Nisoldipine—Musculoskeletal discomfort—Cisplatin—bone cancer	0.000503	0.00266	CcSEcCtD
Nisoldipine—Ataxia—Doxorubicin—bone cancer	0.000501	0.00265	CcSEcCtD
Nisoldipine—Influenza—Epirubicin—bone cancer	0.000498	0.00264	CcSEcCtD
Nisoldipine—Asthma—Epirubicin—bone cancer	0.000498	0.00264	CcSEcCtD
Nisoldipine—Dysphagia—Epirubicin—bone cancer	0.000498	0.00264	CcSEcCtD
Nisoldipine—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.000498	0.0142	CbGpPWpGaD
Nisoldipine—Dysuria—Methotrexate—bone cancer	0.000498	0.00263	CcSEcCtD
Nisoldipine—Paraesthesia—Cisplatin—bone cancer	0.000495	0.00262	CcSEcCtD
Nisoldipine—Liver function test abnormal—Doxorubicin—bone cancer	0.000492	0.00261	CcSEcCtD
Nisoldipine—Dyspnoea—Cisplatin—bone cancer	0.000492	0.0026	CcSEcCtD
Nisoldipine—CACNA1C—Calcium Regulation in the Cardiac Cell—RGS1—bone cancer	0.000492	0.014	CbGpPWpGaD
Nisoldipine—Erectile dysfunction—Methotrexate—bone cancer	0.00049	0.0026	CcSEcCtD
Nisoldipine—CYP3A5—Metapathway biotransformation—CYP4V2—bone cancer	0.00049	0.014	CbGpPWpGaD
Nisoldipine—Dry skin—Doxorubicin—bone cancer	0.000489	0.00259	CcSEcCtD
Nisoldipine—Orthostatic hypotension—Doxorubicin—bone cancer	0.000487	0.00258	CcSEcCtD
Nisoldipine—Hypokalaemia—Doxorubicin—bone cancer	0.000485	0.00257	CcSEcCtD
Nisoldipine—Decreased appetite—Cisplatin—bone cancer	0.000479	0.00254	CcSEcCtD
Nisoldipine—ABCB1—Drug Induction of Bile Acid Pathway—CYP3A4—bone cancer	0.000472	0.0135	CbGpPWpGaD
Nisoldipine—Gastritis—Doxorubicin—bone cancer	0.000472	0.0025	CcSEcCtD
Nisoldipine—Muscular weakness—Doxorubicin—bone cancer	0.00047	0.00249	CcSEcCtD
Nisoldipine—Dysuria—Epirubicin—bone cancer	0.000466	0.00247	CcSEcCtD
Nisoldipine—CACNA1C—Regulation of insulin secretion—GNA11—bone cancer	0.000466	0.0133	CbGpPWpGaD
Nisoldipine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000464	0.0132	CbGpPWpGaD
Nisoldipine—Stomatitis—Methotrexate—bone cancer	0.000463	0.00245	CcSEcCtD
Nisoldipine—Conjunctivitis—Methotrexate—bone cancer	0.000461	0.00244	CcSEcCtD
Nisoldipine—Asthma—Doxorubicin—bone cancer	0.000461	0.00244	CcSEcCtD
Nisoldipine—Influenza—Doxorubicin—bone cancer	0.000461	0.00244	CcSEcCtD
Nisoldipine—Dysphagia—Doxorubicin—bone cancer	0.000461	0.00244	CcSEcCtD
Nisoldipine—Pollakiuria—Epirubicin—bone cancer	0.00046	0.00244	CcSEcCtD
Nisoldipine—Sweating—Methotrexate—bone cancer	0.000455	0.00241	CcSEcCtD
Nisoldipine—Feeling abnormal—Cisplatin—bone cancer	0.000455	0.00241	CcSEcCtD
Nisoldipine—Weight increased—Epirubicin—bone cancer	0.000453	0.0024	CcSEcCtD
Nisoldipine—Haematuria—Methotrexate—bone cancer	0.000452	0.0024	CcSEcCtD
Nisoldipine—Weight decreased—Epirubicin—bone cancer	0.000451	0.00239	CcSEcCtD
Nisoldipine—Epistaxis—Methotrexate—bone cancer	0.000448	0.00237	CcSEcCtD
Nisoldipine—CACNB2—Integration of energy metabolism—GNA11—bone cancer	0.00044	0.0126	CbGpPWpGaD
Nisoldipine—Body temperature increased—Cisplatin—bone cancer	0.000436	0.00231	CcSEcCtD
Nisoldipine—Stomatitis—Epirubicin—bone cancer	0.000433	0.00229	CcSEcCtD
Nisoldipine—Conjunctivitis—Epirubicin—bone cancer	0.000432	0.00229	CcSEcCtD
Nisoldipine—Dysuria—Doxorubicin—bone cancer	0.000431	0.00228	CcSEcCtD
Nisoldipine—Sweating—Epirubicin—bone cancer	0.000426	0.00225	CcSEcCtD
Nisoldipine—Pollakiuria—Doxorubicin—bone cancer	0.000426	0.00225	CcSEcCtD
Nisoldipine—Haematuria—Epirubicin—bone cancer	0.000423	0.00224	CcSEcCtD
Nisoldipine—Pharyngitis—Methotrexate—bone cancer	0.000423	0.00224	CcSEcCtD
Nisoldipine—Weight increased—Doxorubicin—bone cancer	0.000419	0.00222	CcSEcCtD
Nisoldipine—Epistaxis—Epirubicin—bone cancer	0.000419	0.00222	CcSEcCtD
Nisoldipine—Weight decreased—Doxorubicin—bone cancer	0.000417	0.00221	CcSEcCtD
Nisoldipine—CACNA1D—Integration of energy metabolism—GNA11—bone cancer	0.000417	0.0119	CbGpPWpGaD
Nisoldipine—Sinusitis—Epirubicin—bone cancer	0.000417	0.00221	CcSEcCtD
Nisoldipine—Visual impairment—Methotrexate—bone cancer	0.000411	0.00217	CcSEcCtD
Nisoldipine—Hypersensitivity—Cisplatin—bone cancer	0.000406	0.00215	CcSEcCtD
Nisoldipine—Stomatitis—Doxorubicin—bone cancer	0.000401	0.00212	CcSEcCtD
Nisoldipine—Rhinitis—Epirubicin—bone cancer	0.0004	0.00212	CcSEcCtD
Nisoldipine—Conjunctivitis—Doxorubicin—bone cancer	0.000399	0.00211	CcSEcCtD
Nisoldipine—Tinnitus—Methotrexate—bone cancer	0.000397	0.0021	CcSEcCtD
Nisoldipine—Hypoaesthesia—Epirubicin—bone cancer	0.000397	0.0021	CcSEcCtD
Nisoldipine—Pharyngitis—Epirubicin—bone cancer	0.000396	0.00209	CcSEcCtD
Nisoldipine—CYP1A2—Fatty Acid Omega Oxidation—CYP3A4—bone cancer	0.000396	0.0113	CbGpPWpGaD
Nisoldipine—Sweating—Doxorubicin—bone cancer	0.000394	0.00209	CcSEcCtD
Nisoldipine—Oedema peripheral—Epirubicin—bone cancer	0.000393	0.00208	CcSEcCtD
Nisoldipine—Haematuria—Doxorubicin—bone cancer	0.000392	0.00207	CcSEcCtD
Nisoldipine—Epistaxis—Doxorubicin—bone cancer	0.000388	0.00205	CcSEcCtD
Nisoldipine—Sinusitis—Doxorubicin—bone cancer	0.000386	0.00204	CcSEcCtD
Nisoldipine—CACNA1S—Calcium Regulation in the Cardiac Cell—GNA11—bone cancer	0.000385	0.011	CbGpPWpGaD
Nisoldipine—Visual impairment—Epirubicin—bone cancer	0.000384	0.00203	CcSEcCtD
Nisoldipine—Chills—Methotrexate—bone cancer	0.000382	0.00202	CcSEcCtD
Nisoldipine—Diarrhoea—Cisplatin—bone cancer	0.000377	0.002	CcSEcCtD
Nisoldipine—CYP3A5—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000377	0.0108	CbGpPWpGaD
Nisoldipine—Alopecia—Methotrexate—bone cancer	0.000376	0.00199	CcSEcCtD
Nisoldipine—Tinnitus—Epirubicin—bone cancer	0.000372	0.00197	CcSEcCtD
Nisoldipine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000371	0.0106	CbGpPWpGaD
Nisoldipine—Rhinitis—Doxorubicin—bone cancer	0.00037	0.00196	CcSEcCtD
Nisoldipine—Hypoaesthesia—Doxorubicin—bone cancer	0.000367	0.00194	CcSEcCtD
Nisoldipine—CACNA1C—Integration of energy metabolism—GNA11—bone cancer	0.000366	0.0104	CbGpPWpGaD
Nisoldipine—Pharyngitis—Doxorubicin—bone cancer	0.000366	0.00194	CcSEcCtD
Nisoldipine—Oedema peripheral—Doxorubicin—bone cancer	0.000363	0.00192	CcSEcCtD
Nisoldipine—Dysgeusia—Methotrexate—bone cancer	0.000363	0.00192	CcSEcCtD
Nisoldipine—CYP1A2—Estrogen metabolism—CYP3A4—bone cancer	0.00036	0.0103	CbGpPWpGaD
Nisoldipine—Chills—Epirubicin—bone cancer	0.000358	0.00189	CcSEcCtD
Nisoldipine—Visual impairment—Doxorubicin—bone cancer	0.000356	0.00188	CcSEcCtD
Nisoldipine—Alopecia—Epirubicin—bone cancer	0.000352	0.00187	CcSEcCtD
Nisoldipine—Rash—Cisplatin—bone cancer	0.000348	0.00184	CcSEcCtD
Nisoldipine—Dermatitis—Cisplatin—bone cancer	0.000347	0.00184	CcSEcCtD
Nisoldipine—CYP1A2—Aflatoxin activation and detoxification—CYP3A4—bone cancer	0.000345	0.00984	CbGpPWpGaD
Nisoldipine—Ill-defined disorder—Methotrexate—bone cancer	0.000344	0.00182	CcSEcCtD
Nisoldipine—Tinnitus—Doxorubicin—bone cancer	0.000344	0.00182	CcSEcCtD
Nisoldipine—Anaemia—Methotrexate—bone cancer	0.000343	0.00181	CcSEcCtD
Nisoldipine—Flatulence—Epirubicin—bone cancer	0.000342	0.00181	CcSEcCtD
Nisoldipine—Tension—Epirubicin—bone cancer	0.000341	0.0018	CcSEcCtD
Nisoldipine—Dysgeusia—Epirubicin—bone cancer	0.00034	0.0018	CcSEcCtD
Nisoldipine—Nervousness—Epirubicin—bone cancer	0.000337	0.00178	CcSEcCtD
Nisoldipine—Malaise—Methotrexate—bone cancer	0.000334	0.00177	CcSEcCtD
Nisoldipine—Muscle spasms—Epirubicin—bone cancer	0.000334	0.00177	CcSEcCtD
Nisoldipine—Vertigo—Methotrexate—bone cancer	0.000333	0.00176	CcSEcCtD
Nisoldipine—Leukopenia—Methotrexate—bone cancer	0.000332	0.00176	CcSEcCtD
Nisoldipine—Chills—Doxorubicin—bone cancer	0.000331	0.00175	CcSEcCtD
Nisoldipine—CYP1A2—Xenobiotics—CYP3A4—bone cancer	0.000331	0.00944	CbGpPWpGaD
Nisoldipine—Nausea—Cisplatin—bone cancer	0.000328	0.00173	CcSEcCtD
Nisoldipine—Alopecia—Doxorubicin—bone cancer	0.000326	0.00173	CcSEcCtD
Nisoldipine—Cough—Methotrexate—bone cancer	0.000324	0.00171	CcSEcCtD
Nisoldipine—Ill-defined disorder—Epirubicin—bone cancer	0.000322	0.0017	CcSEcCtD
Nisoldipine—Anaemia—Epirubicin—bone cancer	0.000321	0.0017	CcSEcCtD
Nisoldipine—CYP1A2—Tamoxifen metabolism—CYP3A4—bone cancer	0.000318	0.00908	CbGpPWpGaD
Nisoldipine—Flatulence—Doxorubicin—bone cancer	0.000316	0.00168	CcSEcCtD
Nisoldipine—Chest pain—Methotrexate—bone cancer	0.000316	0.00167	CcSEcCtD
Nisoldipine—Myalgia—Methotrexate—bone cancer	0.000316	0.00167	CcSEcCtD
Nisoldipine—Arthralgia—Methotrexate—bone cancer	0.000316	0.00167	CcSEcCtD
Nisoldipine—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000316	0.00901	CbGpPWpGaD
Nisoldipine—Tension—Doxorubicin—bone cancer	0.000315	0.00167	CcSEcCtD
Nisoldipine—Dysgeusia—Doxorubicin—bone cancer	0.000314	0.00166	CcSEcCtD
Nisoldipine—Malaise—Epirubicin—bone cancer	0.000313	0.00166	CcSEcCtD
Nisoldipine—CACNA1D—Calcium Regulation in the Cardiac Cell—GNA11—bone cancer	0.000313	0.00892	CbGpPWpGaD
Nisoldipine—Discomfort—Methotrexate—bone cancer	0.000312	0.00165	CcSEcCtD
Nisoldipine—Nervousness—Doxorubicin—bone cancer	0.000312	0.00165	CcSEcCtD
Nisoldipine—Vertigo—Epirubicin—bone cancer	0.000312	0.00165	CcSEcCtD
Nisoldipine—CYP3A7—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000311	0.00889	CbGpPWpGaD
Nisoldipine—Syncope—Epirubicin—bone cancer	0.000311	0.00165	CcSEcCtD
Nisoldipine—Leukopenia—Epirubicin—bone cancer	0.000311	0.00164	CcSEcCtD
Nisoldipine—Muscle spasms—Doxorubicin—bone cancer	0.000309	0.00163	CcSEcCtD
Nisoldipine—Palpitations—Epirubicin—bone cancer	0.000307	0.00162	CcSEcCtD
Nisoldipine—Confusional state—Methotrexate—bone cancer	0.000305	0.00162	CcSEcCtD
Nisoldipine—Loss of consciousness—Epirubicin—bone cancer	0.000305	0.00161	CcSEcCtD
Nisoldipine—Cough—Epirubicin—bone cancer	0.000303	0.0016	CcSEcCtD
Nisoldipine—Ill-defined disorder—Doxorubicin—bone cancer	0.000298	0.00158	CcSEcCtD
Nisoldipine—Anaemia—Doxorubicin—bone cancer	0.000297	0.00157	CcSEcCtD
Nisoldipine—Arthralgia—Epirubicin—bone cancer	0.000295	0.00156	CcSEcCtD
Nisoldipine—Chest pain—Epirubicin—bone cancer	0.000295	0.00156	CcSEcCtD
Nisoldipine—Myalgia—Epirubicin—bone cancer	0.000295	0.00156	CcSEcCtD
Nisoldipine—CYP1A2—Metapathway biotransformation—CYP4V2—bone cancer	0.000295	0.00842	CbGpPWpGaD
Nisoldipine—Anxiety—Epirubicin—bone cancer	0.000294	0.00156	CcSEcCtD
Nisoldipine—Hyperhidrosis—Methotrexate—bone cancer	0.000293	0.00155	CcSEcCtD
Nisoldipine—Discomfort—Epirubicin—bone cancer	0.000292	0.00155	CcSEcCtD
Nisoldipine—Malaise—Doxorubicin—bone cancer	0.00029	0.00153	CcSEcCtD
Nisoldipine—Dry mouth—Epirubicin—bone cancer	0.000289	0.00153	CcSEcCtD
Nisoldipine—Vertigo—Doxorubicin—bone cancer	0.000289	0.00153	CcSEcCtD
Nisoldipine—Anorexia—Methotrexate—bone cancer	0.000289	0.00153	CcSEcCtD
Nisoldipine—Syncope—Doxorubicin—bone cancer	0.000288	0.00152	CcSEcCtD
Nisoldipine—Leukopenia—Doxorubicin—bone cancer	0.000287	0.00152	CcSEcCtD
Nisoldipine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000286	0.00816	CbGpPWpGaD
Nisoldipine—Confusional state—Epirubicin—bone cancer	0.000286	0.00151	CcSEcCtD
Nisoldipine—ABCB1—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000285	0.00812	CbGpPWpGaD
Nisoldipine—Palpitations—Doxorubicin—bone cancer	0.000284	0.0015	CcSEcCtD
Nisoldipine—Oedema—Epirubicin—bone cancer	0.000283	0.0015	CcSEcCtD
Nisoldipine—Hypotension—Methotrexate—bone cancer	0.000283	0.0015	CcSEcCtD
Nisoldipine—Loss of consciousness—Doxorubicin—bone cancer	0.000282	0.00149	CcSEcCtD
Nisoldipine—Cough—Doxorubicin—bone cancer	0.00028	0.00148	CcSEcCtD
Nisoldipine—Shock—Epirubicin—bone cancer	0.000279	0.00148	CcSEcCtD
Nisoldipine—Tachycardia—Epirubicin—bone cancer	0.000276	0.00146	CcSEcCtD
Nisoldipine—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000276	0.00146	CcSEcCtD
Nisoldipine—CACNA1C—Calcium Regulation in the Cardiac Cell—GNA11—bone cancer	0.000275	0.00784	CbGpPWpGaD
Nisoldipine—Hyperhidrosis—Epirubicin—bone cancer	0.000274	0.00145	CcSEcCtD
Nisoldipine—Insomnia—Methotrexate—bone cancer	0.000274	0.00145	CcSEcCtD
Nisoldipine—Chest pain—Doxorubicin—bone cancer	0.000273	0.00145	CcSEcCtD
Nisoldipine—Arthralgia—Doxorubicin—bone cancer	0.000273	0.00145	CcSEcCtD
Nisoldipine—Myalgia—Doxorubicin—bone cancer	0.000273	0.00145	CcSEcCtD
Nisoldipine—Anxiety—Doxorubicin—bone cancer	0.000272	0.00144	CcSEcCtD
Nisoldipine—Paraesthesia—Methotrexate—bone cancer	0.000272	0.00144	CcSEcCtD
Nisoldipine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000271	0.00774	CbGpPWpGaD
Nisoldipine—Discomfort—Doxorubicin—bone cancer	0.00027	0.00143	CcSEcCtD
Nisoldipine—Anorexia—Epirubicin—bone cancer	0.00027	0.00143	CcSEcCtD
Nisoldipine—Dyspnoea—Methotrexate—bone cancer	0.00027	0.00143	CcSEcCtD
Nisoldipine—Somnolence—Methotrexate—bone cancer	0.000269	0.00142	CcSEcCtD
Nisoldipine—Dry mouth—Doxorubicin—bone cancer	0.000267	0.00142	CcSEcCtD
Nisoldipine—Dyspepsia—Methotrexate—bone cancer	0.000266	0.00141	CcSEcCtD
Nisoldipine—Hypotension—Epirubicin—bone cancer	0.000265	0.0014	CcSEcCtD
Nisoldipine—Confusional state—Doxorubicin—bone cancer	0.000264	0.0014	CcSEcCtD
Nisoldipine—Decreased appetite—Methotrexate—bone cancer	0.000263	0.00139	CcSEcCtD
Nisoldipine—Oedema—Doxorubicin—bone cancer	0.000262	0.00139	CcSEcCtD
Nisoldipine—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000258	0.00137	CcSEcCtD
Nisoldipine—Shock—Doxorubicin—bone cancer	0.000258	0.00137	CcSEcCtD
Nisoldipine—Insomnia—Epirubicin—bone cancer	0.000256	0.00136	CcSEcCtD
Nisoldipine—CYP3A7—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000256	0.0073	CbGpPWpGaD
Nisoldipine—Tachycardia—Doxorubicin—bone cancer	0.000256	0.00135	CcSEcCtD
Nisoldipine—Paraesthesia—Epirubicin—bone cancer	0.000254	0.00135	CcSEcCtD
Nisoldipine—Hyperhidrosis—Doxorubicin—bone cancer	0.000253	0.00134	CcSEcCtD
Nisoldipine—Dyspnoea—Epirubicin—bone cancer	0.000253	0.00134	CcSEcCtD
Nisoldipine—Somnolence—Epirubicin—bone cancer	0.000252	0.00133	CcSEcCtD
Nisoldipine—Anorexia—Doxorubicin—bone cancer	0.00025	0.00132	CcSEcCtD
Nisoldipine—Feeling abnormal—Methotrexate—bone cancer	0.000249	0.00132	CcSEcCtD
Nisoldipine—Dyspepsia—Epirubicin—bone cancer	0.000249	0.00132	CcSEcCtD
Nisoldipine—Decreased appetite—Epirubicin—bone cancer	0.000246	0.0013	CcSEcCtD
Nisoldipine—Hypotension—Doxorubicin—bone cancer	0.000245	0.0013	CcSEcCtD
Nisoldipine—Urticaria—Methotrexate—bone cancer	0.00024	0.00127	CcSEcCtD
Nisoldipine—Body temperature increased—Methotrexate—bone cancer	0.000239	0.00127	CcSEcCtD
Nisoldipine—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000239	0.00126	CcSEcCtD
Nisoldipine—Insomnia—Doxorubicin—bone cancer	0.000237	0.00125	CcSEcCtD
Nisoldipine—CACNA1S—tendon—bone cancer	0.000236	0.0598	CbGeAlD
Nisoldipine—Paraesthesia—Doxorubicin—bone cancer	0.000235	0.00125	CcSEcCtD
Nisoldipine—Dyspnoea—Doxorubicin—bone cancer	0.000234	0.00124	CcSEcCtD
Nisoldipine—Feeling abnormal—Epirubicin—bone cancer	0.000233	0.00124	CcSEcCtD
Nisoldipine—Somnolence—Doxorubicin—bone cancer	0.000233	0.00123	CcSEcCtD
Nisoldipine—Dyspepsia—Doxorubicin—bone cancer	0.000231	0.00122	CcSEcCtD
Nisoldipine—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000228	0.00651	CbGpPWpGaD
Nisoldipine—Decreased appetite—Doxorubicin—bone cancer	0.000228	0.00121	CcSEcCtD
Nisoldipine—CYP3A4—Metapathway biotransformation—CYP4V2—bone cancer	0.000228	0.0065	CbGpPWpGaD
Nisoldipine—CYP3A5—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000225	0.00642	CbGpPWpGaD
Nisoldipine—Urticaria—Epirubicin—bone cancer	0.000225	0.00119	CcSEcCtD
Nisoldipine—Body temperature increased—Epirubicin—bone cancer	0.000224	0.00119	CcSEcCtD
Nisoldipine—Hypersensitivity—Methotrexate—bone cancer	0.000223	0.00118	CcSEcCtD
Nisoldipine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000216	0.00618	CbGpPWpGaD
Nisoldipine—Feeling abnormal—Doxorubicin—bone cancer	0.000216	0.00114	CcSEcCtD
Nisoldipine—Pruritus—Methotrexate—bone cancer	0.000214	0.00113	CcSEcCtD
Nisoldipine—Hypersensitivity—Epirubicin—bone cancer	0.000209	0.0011	CcSEcCtD
Nisoldipine—Urticaria—Doxorubicin—bone cancer	0.000208	0.0011	CcSEcCtD
Nisoldipine—Body temperature increased—Doxorubicin—bone cancer	0.000207	0.0011	CcSEcCtD
Nisoldipine—Diarrhoea—Methotrexate—bone cancer	0.000207	0.0011	CcSEcCtD
Nisoldipine—Pruritus—Epirubicin—bone cancer	0.0002	0.00106	CcSEcCtD
Nisoldipine—Dizziness—Methotrexate—bone cancer	0.0002	0.00106	CcSEcCtD
Nisoldipine—Diarrhoea—Epirubicin—bone cancer	0.000194	0.00103	CcSEcCtD
Nisoldipine—Hypersensitivity—Doxorubicin—bone cancer	0.000193	0.00102	CcSEcCtD
Nisoldipine—Rash—Methotrexate—bone cancer	0.000191	0.00101	CcSEcCtD
Nisoldipine—Dermatitis—Methotrexate—bone cancer	0.000191	0.00101	CcSEcCtD
Nisoldipine—Headache—Methotrexate—bone cancer	0.00019	0.001	CcSEcCtD
Nisoldipine—Dizziness—Epirubicin—bone cancer	0.000187	0.000992	CcSEcCtD
Nisoldipine—CYP1A2—Estrogen Receptor Pathway—JUN—bone cancer	0.000187	0.00532	CbGpPWpGaD
Nisoldipine—Pruritus—Doxorubicin—bone cancer	0.000185	0.000982	CcSEcCtD
Nisoldipine—CYP3A5—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000185	0.00528	CbGpPWpGaD
Nisoldipine—Nausea—Methotrexate—bone cancer	0.00018	0.000952	CcSEcCtD
Nisoldipine—Diarrhoea—Doxorubicin—bone cancer	0.000179	0.000949	CcSEcCtD
Nisoldipine—Rash—Epirubicin—bone cancer	0.000179	0.000946	CcSEcCtD
Nisoldipine—Dermatitis—Epirubicin—bone cancer	0.000178	0.000945	CcSEcCtD
Nisoldipine—Headache—Epirubicin—bone cancer	0.000177	0.000939	CcSEcCtD
Nisoldipine—Dizziness—Doxorubicin—bone cancer	0.000173	0.000918	CcSEcCtD
Nisoldipine—CYP1A2—Tryptophan metabolism—CYP3A4—bone cancer	0.00017	0.00485	CbGpPWpGaD
Nisoldipine—Nausea—Epirubicin—bone cancer	0.000168	0.000891	CcSEcCtD
Nisoldipine—CACNA1C—connective tissue—bone cancer	0.000166	0.0422	CbGeAlD
Nisoldipine—Rash—Doxorubicin—bone cancer	0.000165	0.000875	CcSEcCtD
Nisoldipine—Dermatitis—Doxorubicin—bone cancer	0.000165	0.000874	CcSEcCtD
Nisoldipine—Headache—Doxorubicin—bone cancer	0.000164	0.000869	CcSEcCtD
Nisoldipine—CACNB2—Metabolism—NDUFA12—bone cancer	0.00016	0.00456	CbGpPWpGaD
Nisoldipine—Nausea—Doxorubicin—bone cancer	0.000156	0.000824	CcSEcCtD
Nisoldipine—CACNA1S—Alzheimers Disease—TP53—bone cancer	0.000153	0.00436	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—NDUFA12—bone cancer	0.000151	0.00432	CbGpPWpGaD
Nisoldipine—CACNB2—tendon—bone cancer	0.000142	0.0359	CbGeAlD
Nisoldipine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000137	0.00392	CbGpPWpGaD
Nisoldipine—CYP3A7—Biological oxidations—CYP3A4—bone cancer	0.000136	0.00388	CbGpPWpGaD
Nisoldipine—CYP1A2—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000136	0.00387	CbGpPWpGaD
Nisoldipine—CYP3A7—Metapathway biotransformation—CYP3A4—bone cancer	0.000134	0.00382	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—NDUFA12—bone cancer	0.000133	0.0038	CbGpPWpGaD
Nisoldipine—CACNA2D1—tendon—bone cancer	0.000133	0.0337	CbGeAlD
Nisoldipine—CACNB2—Metabolism—NT5C3A—bone cancer	0.000132	0.00378	CbGpPWpGaD
Nisoldipine—CACNB2—Transmission across Chemical Synapses—BRAF—bone cancer	0.00013	0.0037	CbGpPWpGaD
Nisoldipine—CACNA2D1—bone marrow—bone cancer	0.000129	0.0327	CbGeAlD
Nisoldipine—CACNA1D—Metabolism—NT5C3A—bone cancer	0.000125	0.00358	CbGpPWpGaD
Nisoldipine—CACNA1D—Alzheimers Disease—TP53—bone cancer	0.000124	0.00354	CbGpPWpGaD
Nisoldipine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—bone cancer	0.000118	0.00337	CbGpPWpGaD
Nisoldipine—CYP3A7—Biological oxidations—GSTP1—bone cancer	0.000116	0.00332	CbGpPWpGaD
Nisoldipine—CACNA1S—Axon guidance—MET—bone cancer	0.000116	0.00332	CbGpPWpGaD
Nisoldipine—CYP3A7—Metapathway biotransformation—GSTP1—bone cancer	0.000115	0.00327	CbGpPWpGaD
Nisoldipine—CYP1A2—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000111	0.00318	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—NT5C3A—bone cancer	0.00011	0.00315	CbGpPWpGaD
Nisoldipine—CACNA1C—Alzheimers Disease—TP53—bone cancer	0.000109	0.00311	CbGpPWpGaD
Nisoldipine—CACNB2—Transmission across Chemical Synapses—MDM2—bone cancer	0.000109	0.0031	CbGpPWpGaD
Nisoldipine—CACNB2—Axon guidance—MET—bone cancer	9.96e-05	0.00284	CbGpPWpGaD
Nisoldipine—CACNB2—Neuronal System—BRAF—bone cancer	9.94e-05	0.00284	CbGpPWpGaD
Nisoldipine—CYP3A5—Biological oxidations—CYP3A4—bone cancer	9.83e-05	0.0028	CbGpPWpGaD
Nisoldipine—CACNA1S—Axon guidance—MMP2—bone cancer	9.69e-05	0.00277	CbGpPWpGaD
Nisoldipine—CYP3A5—Metapathway biotransformation—CYP3A4—bone cancer	9.69e-05	0.00276	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	9.67e-05	0.00276	CbGpPWpGaD
Nisoldipine—CACNA1D—Axon guidance—MET—bone cancer	9.44e-05	0.00269	CbGpPWpGaD
Nisoldipine—CYP1A2—Aryl Hydrocarbon Receptor—RB1—bone cancer	9.16e-05	0.00261	CbGpPWpGaD
Nisoldipine—CYP1A2—Phase II conjugation—GSTP1—bone cancer	8.65e-05	0.00247	CbGpPWpGaD
Nisoldipine—CYP3A5—Biological oxidations—GSTP1—bone cancer	8.4e-05	0.0024	CbGpPWpGaD
Nisoldipine—CACNB2—Neuronal System—MDM2—bone cancer	8.33e-05	0.00238	CbGpPWpGaD
Nisoldipine—CACNB2—Axon guidance—MMP2—bone cancer	8.31e-05	0.00237	CbGpPWpGaD
Nisoldipine—CACNA1S—Developmental Biology—CDK4—bone cancer	8.29e-05	0.00237	CbGpPWpGaD
Nisoldipine—CACNA1S—Developmental Biology—MET—bone cancer	8.29e-05	0.00237	CbGpPWpGaD
Nisoldipine—CACNA1C—Axon guidance—MET—bone cancer	8.29e-05	0.00237	CbGpPWpGaD
Nisoldipine—CYP3A5—Metapathway biotransformation—GSTP1—bone cancer	8.29e-05	0.00236	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	8.22e-05	0.00235	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—NDUFA12—bone cancer	8.15e-05	0.00232	CbGpPWpGaD
Nisoldipine—CACNA1D—Axon guidance—MMP2—bone cancer	7.87e-05	0.00225	CbGpPWpGaD
Nisoldipine—CYP1A2—Tryptophan metabolism—MDM2—bone cancer	7.81e-05	0.00223	CbGpPWpGaD
Nisoldipine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—bone cancer	7.53e-05	0.00215	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	7.49e-05	0.00214	CbGpPWpGaD
Nisoldipine—CACNA1S—Axon guidance—MMP9—bone cancer	7.29e-05	0.00208	CbGpPWpGaD
Nisoldipine—CACNB2—Developmental Biology—CDK4—bone cancer	7.11e-05	0.00203	CbGpPWpGaD
Nisoldipine—CACNB2—Developmental Biology—MET—bone cancer	7.11e-05	0.00203	CbGpPWpGaD
Nisoldipine—CYP1A2—Arachidonic acid metabolism—PTGS2—bone cancer	7.05e-05	0.00201	CbGpPWpGaD
Nisoldipine—CACNA1S—Developmental Biology—MMP2—bone cancer	6.92e-05	0.00197	CbGpPWpGaD
Nisoldipine—CACNA1C—Axon guidance—MMP2—bone cancer	6.92e-05	0.00197	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	6.82e-05	0.00195	CbGpPWpGaD
Nisoldipine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—bone cancer	6.79e-05	0.00194	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—NT5C3A—bone cancer	6.75e-05	0.00193	CbGpPWpGaD
Nisoldipine—CACNA1D—Developmental Biology—CDK4—bone cancer	6.73e-05	0.00192	CbGpPWpGaD
Nisoldipine—CACNA1D—Developmental Biology—MET—bone cancer	6.73e-05	0.00192	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	6.73e-05	0.00192	CbGpPWpGaD
Nisoldipine—ABCB1—HIF-1-alpha transcription factor network—JUN—bone cancer	6.37e-05	0.00182	CbGpPWpGaD
Nisoldipine—CACNB2—Axon guidance—MMP9—bone cancer	6.25e-05	0.00178	CbGpPWpGaD
Nisoldipine—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	6.03e-05	0.00172	CbGpPWpGaD
Nisoldipine—CACNB2—Developmental Biology—MMP2—bone cancer	5.93e-05	0.00169	CbGpPWpGaD
Nisoldipine—CYP1A2—Biological oxidations—CYP3A4—bone cancer	5.92e-05	0.00169	CbGpPWpGaD
Nisoldipine—CACNA1C—Developmental Biology—MET—bone cancer	5.92e-05	0.00169	CbGpPWpGaD
Nisoldipine—CACNA1C—Developmental Biology—CDK4—bone cancer	5.92e-05	0.00169	CbGpPWpGaD
Nisoldipine—CACNA1D—Axon guidance—MMP9—bone cancer	5.92e-05	0.00169	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—NDUFA12—bone cancer	5.89e-05	0.00168	CbGpPWpGaD
Nisoldipine—CACNA1S—Axon guidance—EGFR—bone cancer	5.89e-05	0.00168	CbGpPWpGaD
Nisoldipine—CYP1A2—Metapathway biotransformation—CYP3A4—bone cancer	5.84e-05	0.00167	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—ENO2—bone cancer	5.8e-05	0.00166	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	5.7e-05	0.00163	CbGpPWpGaD
Nisoldipine—ABCB1—Transmembrane transport of small molecules—TUBB4B—bone cancer	5.68e-05	0.00162	CbGpPWpGaD
Nisoldipine—CACNA1D—Developmental Biology—MMP2—bone cancer	5.62e-05	0.0016	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—ENO2—bone cancer	5.5e-05	0.00157	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—DHFR—bone cancer	5.38e-05	0.00154	CbGpPWpGaD
Nisoldipine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	5.34e-05	0.00152	CbGpPWpGaD
Nisoldipine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—bone cancer	5.34e-05	0.00152	CbGpPWpGaD
Nisoldipine—CACNA1S—Developmental Biology—MMP9—bone cancer	5.2e-05	0.00148	CbGpPWpGaD
Nisoldipine—CACNA1C—Axon guidance—MMP9—bone cancer	5.2e-05	0.00148	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—DHFR—bone cancer	5.1e-05	0.00145	CbGpPWpGaD
Nisoldipine—CYP1A2—Biological oxidations—GSTP1—bone cancer	5.06e-05	0.00144	CbGpPWpGaD
Nisoldipine—CACNB2—Axon guidance—EGFR—bone cancer	5.05e-05	0.00144	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—GNA11—bone cancer	5.03e-05	0.00144	CbGpPWpGaD
Nisoldipine—CYP1A2—Metapathway biotransformation—GSTP1—bone cancer	4.99e-05	0.00142	CbGpPWpGaD
Nisoldipine—CACNA1C—Developmental Biology—MMP2—bone cancer	4.94e-05	0.00141	CbGpPWpGaD
Nisoldipine—ABCB1—Transmembrane transport of small molecules—TUBB2A—bone cancer	4.91e-05	0.0014	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—NT5C3A—bone cancer	4.88e-05	0.00139	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—ENO2—bone cancer	4.83e-05	0.00138	CbGpPWpGaD
Nisoldipine—CACNA1D—Axon guidance—EGFR—bone cancer	4.78e-05	0.00136	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—GNA11—bone cancer	4.77e-05	0.00136	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—CYP3A4—bone cancer	4.56e-05	0.0013	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—DHFR—bone cancer	4.48e-05	0.00128	CbGpPWpGaD
Nisoldipine—CACNB2—Developmental Biology—MMP9—bone cancer	4.46e-05	0.00127	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—NDUFA12—bone cancer	4.44e-05	0.00127	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—CYP3A4—bone cancer	4.32e-05	0.00123	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	4.23e-05	0.00121	CbGpPWpGaD
Nisoldipine—CACNA1D—Developmental Biology—MMP9—bone cancer	4.22e-05	0.0012	CbGpPWpGaD
Nisoldipine—CACNA1S—Developmental Biology—EGFR—bone cancer	4.2e-05	0.0012	CbGpPWpGaD
Nisoldipine—CACNA1C—Axon guidance—EGFR—bone cancer	4.2e-05	0.0012	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—GNA11—bone cancer	4.19e-05	0.00119	CbGpPWpGaD
Nisoldipine—CYP3A4—Biological oxidations—GSTP1—bone cancer	3.91e-05	0.00111	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—GSTP1—bone cancer	3.9e-05	0.00111	CbGpPWpGaD
Nisoldipine—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	3.85e-05	0.0011	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—CYP3A4—bone cancer	3.8e-05	0.00108	CbGpPWpGaD
Nisoldipine—CACNA1C—Developmental Biology—MMP9—bone cancer	3.71e-05	0.00106	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—GSTP1—bone cancer	3.69e-05	0.00105	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—NT5C3A—bone cancer	3.68e-05	0.00105	CbGpPWpGaD
Nisoldipine—CACNB2—Developmental Biology—EGFR—bone cancer	3.6e-05	0.00103	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—NDUFA12—bone cancer	3.55e-05	0.00101	CbGpPWpGaD
Nisoldipine—CACNA1D—Developmental Biology—EGFR—bone cancer	3.41e-05	0.000973	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—GSTP1—bone cancer	3.25e-05	0.000926	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	3.13e-05	0.000894	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	3.02e-05	0.000862	CbGpPWpGaD
Nisoldipine—CACNA1C—Developmental Biology—EGFR—bone cancer	3e-05	0.000855	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—ENO2—bone cancer	2.96e-05	0.000844	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—NT5C3A—bone cancer	2.94e-05	0.000839	CbGpPWpGaD
Nisoldipine—ABCB1—bone marrow—bone cancer	2.89e-05	0.00734	CbGeAlD
Nisoldipine—ABCB1—spinal cord—bone cancer	2.88e-05	0.00731	CbGeAlD
Nisoldipine—CYP3A7—Metabolism—DHFR—bone cancer	2.74e-05	0.000783	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—NDUFA12—bone cancer	2.74e-05	0.000781	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	2.72e-05	0.000777	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—GNA11—bone cancer	2.56e-05	0.000732	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—CYP3A4—bone cancer	2.32e-05	0.000663	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—NT5C3A—bone cancer	2.27e-05	0.000647	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	2.14e-05	0.000611	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—ENO2—bone cancer	2.14e-05	0.00061	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—PTGS2—bone cancer	2.02e-05	0.000577	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—GSTP1—bone cancer	1.99e-05	0.000567	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—DHFR—bone cancer	1.98e-05	0.000566	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—PTGS2—bone cancer	1.91e-05	0.000546	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—GNA11—bone cancer	1.85e-05	0.000529	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	1.8e-05	0.000513	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—PTGS2—bone cancer	1.68e-05	0.00048	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—CYP3A4—bone cancer	1.68e-05	0.000479	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—ENO2—bone cancer	1.61e-05	0.00046	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—DHFR—bone cancer	1.5e-05	0.000427	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—GSTP1—bone cancer	1.44e-05	0.00041	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—GNA11—bone cancer	1.4e-05	0.000399	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—ENO2—bone cancer	1.29e-05	0.000367	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—CYP3A4—bone cancer	1.27e-05	0.000362	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—DHFR—bone cancer	1.19e-05	0.000341	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—GNA11—bone cancer	1.12e-05	0.000319	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—GSTP1—bone cancer	1.08e-05	0.000309	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—PTGS2—bone cancer	1.03e-05	0.000294	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—CYP3A4—bone cancer	1.01e-05	0.000289	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.01e-05	0.000287	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—ENO2—bone cancer	9.94e-06	0.000284	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—DHFR—bone cancer	9.22e-06	0.000263	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—GSTP1—bone cancer	8.66e-06	0.000247	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—GNA11—bone cancer	8.62e-06	0.000246	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—PTGS2—bone cancer	7.44e-06	0.000212	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—GSTP1—bone cancer	6.68e-06	0.000191	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—PTGS2—bone cancer	5.62e-06	0.00016	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—PTGS2—bone cancer	4.48e-06	0.000128	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—PTGS2—bone cancer	3.46e-06	9.88e-05	CbGpPWpGaD
